SON-1010 is under clinical development by Sonnet BioTherapeutics and currently in Phase I for Non-Small Cell Lung Cancer.

Vertex Pharmaceuticals offers promising opportunities in pain management, cystic fibrosis treatments, and a diversified ...

APX-3330 is under clinical development by Opus Genetics and currently in Phase II for Non-Proliferative Diabetic Retinopathy (NPDR).

Numbness in your feet is a symptom of diabetic ... detection and treatment of neuropathy is important for preventing complications. Foot numbness is a common symptom of peripheral neuropathy ...

Although the heart has its own nervous system, its organization and functionality remain largely unknown. Here, the authors reveal the molecular, chemical, and functional diversity of neurons ...

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced the U.S. Food and Drug Administration (FDA) ...

This article examines the possible causes of dizziness in type 2 diabetes in more detail, other symptoms to be aware of, treatment options ... a half cup of juice or non-diet soda 1 tablespoon ...

Shares of Vertex Pharmaceuticals Incorporated VRTX were down 11.4% yesterday after the company announced data from a phase II ...

Vertex stock plummeted Thursday after the company's pain drug proved it's no better than a placebo in patients with lower ...

Diabetic socks are specially designed to keep feet dry, decrease the risk of foot injury, and enhance blood circulation. They are a key part of foot care, which is an important aspect of diabetes ...

“SiteOne Therapeutics is committed to developing non-opioid treatments for conditions that involve hyperexcitability of the peripheral nervous system such as pain and cough. Our strategy is ...

SiteOne Therapeutics is powering up with $100 million to advance its early pipeline of non-opioid therapeutics that target the peripheral ... nonaddictive oral pain treatment slated to arrive ...